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Abstract
Background: Kaempferol, a kind of flavonol, has been reported to possess various osteogenic biological activities,
such as inhibiting bone resorption of osteoclasts and promoting the differentiation and mineralization of
preosteoblasts. However, the precise cellular mechanism of action of kaempferol in osteogenesis is elusive.
Autophagy is a major intracellular degradation system, which plays an important role in cell growth, survival, differentiation
and homeostasis in mammals. Recent studies showed that autophagy appeared to be involved in the degradation of
osteoclasts, osteoblasts and osteocytes, potentially pointing to a new pathogenic mechanism of bone homeostasis and
bone marrow disease. The potential correlation between autophagy, osteogenesis and flavonoids is unclear.
Methods: The present study verified that kaempferol promoted osteogenic differentiation and mineralization and that it
elevated osteogenic gene expression based on alkaline phosphatase (ALP) activity, alizarin red staining and quantitative
PCR. And then we found that kaempferol induced autophagy by acridine orange (AO) and monodansylcadaverine (MDC)
staining and autophagy-related protein expression. The correlation between kaempferol-induced autophagy and the
osteogenic process was confirmed by the autophagy inhibitor 3-methyladenine (3-MA).
Results: Kaempferol promoted the proliferation, differentiation and mineralization of osteoblasts at a concentration of
10 μM. Kaempferol showed cytotoxic properties at concentrations above 50 μM. Concentrations above 10 μM
decreased ALP activity, whereas those up to 10 μM increased ALP activity. Kaempferol at concentrations up to 10 μM
also increased the expression of the osteoblast- activated factors RUNX-2, osterix, BMP-2 and collagen I according to
RT-PCR analyses. 10 μM or less, the higher of the concentration and over time, kaempferol promoted the activity of
osteoblasts. Kaempferol induced autophagy. It also increased the expression of the autophagy-related factors beclin-1,
SQSTM1/p62 and the conversion of LC3-II from LC3-I. The application of 3-MA decreased the activity of ALP and the
autophagy induced by kaempferol. In the RT-PCR analysis, the expression of RUNX-2, osterix, BMP-2 and collagen I was
decreased.
Conclusion: The present study showed that kaempferol stimulated the osteogenic differentiation of cultured
osteoblasts by inducing autophagy.
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Background
Bone is a dynamic tissue that is continuously changed by
the bone remodeling process [1, 2]. The bone remodel-
ing process involves bone resorption by osteoclasts,
followed by bone formation by osteoblasts [3]. Osteopor-
osis is a well-known bone metabolic disease that occurs
due to a decrease in bone mass and density caused by a
bone remodeling imbalance [4]. Bone metabolic disor-
ders may result in bone fractures, morbidity and a short-
ened lifespan [1]. Osteoporosis prevention and bone
mass regeneration remain a challenge.
Flavonoids, small polyphenolic molecules commonly
found in roots, leaves and fruits of dietary plants, have
well-known antioxidant, anti-inflammatory, anticancer
and antibacterial activities [5–7]. All flavonoids are
composed of two phenolic rings, which are connected
by a 3-carbon unit. They are classified as flavonols, fla-
vones, flavanones, isoflavones, catechins, anthocyanidins
and chalcones according to the hydroxylation and oxida-
tion binding positions of their chemical structures (Fig. 1)
[8, 9]. Several recent studies have reported that flavo-
noids, such as genistein, icariin, quercetin, taxifolin and
kaempferol have osteogenic, antiosteoclastogenic and
antiadipogenic effects [10–13].
Kaempferol, a kind of flavonol, is derived from the rhi-
zome of Kaempferia galanga L., which is used in trad-
itional medicine in Asia for hypertension, abdominal
pain, headaches and rheumatism [14, 15]. Kaempferol
has been reported to possess various osteogenic bio-
logical activities, such as inhibiting bone resorption of
osteoclasts [15] and promoting the differentiation and
mineralization of preosteoblasts [16, 17]. However, the
precise cellular mechanism of action of kaempferol in
osteogenesis is elusive.
Autophagy is a major intracellular degradation system,
which plays an important role in cell growth, survival,
differentiation and homeostasis in mammals [18]. Vari-
ous stimuli induce autophagy, including stress, cyto-
kines, pathogens, protein aggregation and damaged or
surplus organelles, which are recycled to produce energy
for cellular repair and homeostasis [19]. Recent studies
showed that autophagy appeared to be involved in the
degradation of osteoclasts, osteoblasts and osteocytes,
potentially pointing to a new pathogenic mechanism of
bone homeostasis and bone marrow disease [20].
The potential correlation between autophagy, osteo-
genesis and flavonoids is unclear. The aim of this study
was that kaempferol promoted both bone formation and
autophagy and that kaempferol-induced autophagy
played a major role in controlling the osteogenic process
in MC3T3-E1 osteoblastic cells.
Methods
Reagents
The reagents kaempferol, 3-[4,5-dimethylthiazol-2-yl]2,5-
diphenyl tetrazolium bromide (MTT), MDC, and AO,
were purchased from Sigma (St. Louis, MO, USA). The
reagent 3-MA (a type-III phosphatidylinositol 3-kinase
[PI-3K] inhibitor) was obtained from Calbiochem (La
Jolla, CA, USA). Antibodies against beclin-1 and ATG5
were purchased from Cell Signaling Technology (Beverly,
MA, USA). Antibodies against LC3 (Sigma, Louis, MO,
USA) were also used. SQSTM1/p62, β-actin antibody,
mouse anti-rabbit IgG antibody and rabbit antimouse
IgG antibodies were purchased from Santa Cruz
Fig. 1 Flavonoid structure. a The chemical structure of different
flavonoids and (b) the chemical structure of kaempferol
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Biotechnology (Santa Cruz, CA, USA). All other che-
micals and reagents were purchased from Sigma, un-
less otherwise specified.
Cell culture
MC3T3-E1 cells, a clonal mouse osteoblastic cell line,
were purchased from ATCC (Rockville, MD, USA). The
cells were cultured in alpha-modified Eagle’s medium
(α-MEM), without ascorbic acid (Gibco BRL, Gland
Island, NY, USA), with 10 % fetal bovine serum (FBS)
and 1 % penicillin-streptomycin at 37 °C. To induce dif-
ferentiation, the cells were seeded onto a 24-well culture
plate and allowed to reach confluence. At confluence
(day 0), the cells were transferred to α-MEM containing
10 % FBS, 1 % penicillin-streptomycin, 10 mM of β-glyc-
erophosphate, and 100 μg/ml of ascorbic acid and then
incubated for different intervals (3, 7, and 14 days) in a
humidified atmosphere of CO2 at 37 °C.
Treatment with kaempferol
Stock solutions of kaempferol (100 mM) were made
by dissolving them in DMSO, followed by freezing at
−20 °C until use. The stock was diluted to their con-
centration with α-MEM when needed. Prior to the
kaempferol treatment, the cells were grown to about
80–100 % confluence and then exposed to kaempferol
at different concentrations (0.1–1000 μM) for at least
24 h, up to 14 days. Cells grown in medium
containing an equivalent amount of DMSO without
kaempferol served as a control. For autophagy con-
trol, the cells were grown in Earle’s balanced salt
solution (EBSS).
MTT assay
Cell proliferation was performed using an MTT assay ac-
cording to the manufacturer’s instructions. The cells
(1 × 104) were cultured in a 96-well plate and incubated
for 24 h. They were treated with kaempferol at various
concentrations (0.1–1000 μM) for 24–72 h. After the
treatment, 100 μl of MTT (final concentration of
0.5 mg/ml) were added and incubated for an additional
4 h at 37 °C to induce the production of formazan crys-
tals, and the supernatants were discarded. The medium
was aspirated, and formazan crystals that formed were
dissolved in DMSO. Cell viability was monitored on an
ELISA reader (Sunrise Remote Control, Tecan, Austria)
at an excitation emission wavelength of 570 nm.
Measurement of alkaline phosphatase (ALP) activity
To investigate osteogenic differentiation, the cells were
treated with 10 μM of kaempferol, and the ALP activity
was determined 3 and 7 days later. The cells were plated
in 6-well plates at a density of 2 × 105 cells/well. The
protein fraction protocol was using previous method
[21]. The ALP activity in the cellular fraction was mea-
sured with an Alkaline Phosphatase Assay Kit (Abcam,
Cambridge, MA, USA). A standard curve was created
using p-nitrophenol as a standard, and each value was
normalized to the protein concentration. The ALP activ-
ity of each sample was normalized by the protein con-
centration and measured by ELISA reader at 405 nm.
Alizarin red staining
The day 7 and 14 samples were fixed in 4 % paraformalde-
hyde for 15 min. To detect calcium deposition, the cells
were stained with 2 % alizarin red solution (pH 4.2) for
10 min and washed twice with distilled water. For quanti-
fication, the cells were destained with 10 % w/v cetylpyri-
dinium chloride for 30 min at room temperature and
transferred to a 96-well plate, and the absorbance was
measured at 550 nm using an ELISA reader.
Acridine orange (AO) and monodansycadaverine (MDC)
staining
The cells were grown on coverslips and treated with
kaempferol. After 24 h, they were stained with 50 μM of
MDC, a selective fluorescent marker for autophagic vac-
uoles [22], at 37 °C for 30 min. The cellular fluorescence
changes were observed using a fluorescence microscope
(Axioskop, Carl Zeiss, Germany). As an autophagy con-
trol, the cells were starved using EBSS. Autophagy is
characterized by acidic vesicles formation as described
previously [23]. For further detection of the acidic cellu-
lar compartment, AO was used. AO emits bright red
fluorescence in acidic vesicles but fluoresces green in
the cytoplasm and nucleus [23]. The cells were
stained with 0.1 μg/ml of AO for 15 min and washed
with PBS. The formation of acidic vesicular organelles
(AVOs) was evaluated under a confocal microscope
LSM 700 (Carl Zeiss, Germany).
Western blot assay
The cells were plated at a density of 2 × 106 cells in
100 mm culture dishes. They were washed twice with
ice-cold PBS and centrifuged at 2,000 rpm for
10 min. The total cell proteins were lysed with an
RIPA buffer (300 mM NaCl, 50 mM Tris-HCl
[pH 7.6], 0.5 % TritonX-100, 2 mM PMSF, 2 μg/ml
aprotinin, and 2 μg/ml leupeptin) and incubated at
4 °C for 1 h. The lysates were centrifuged at 14,000
revolutions per min for 15 min at 4 °C, and sodium
dodecyl sulfate (SDS) and sodium deoxycholic acid
(final concentration of 0.2 %) were added. The pro-
tein concentrations of the cell lysates were deter-
mined with a Bradford protein assay (Bio-Rad,
Richmond, CA, USA), and BSA was used as a protein
standard. A sample of 20 μg of protein in each well
was separated and loaded onto 7.5–15 % SDS/PAGE
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gels. The gels were transferred to PVDF (Amersham
GE Healthcare, Little Chalfont, UK) and reacted with
each antibody. Immunostaining with antibodies was
performed with a SuperSignal West Femto-enhanced
chemiluminescence substrate and detected with an
Alpha Imager HP (Alpha Innotech, Santa Clara,
USA). Equivalent protein loading was confirmed by
Ponceau S staining.
Real-time PCR
Total RNA was removed from the cultured MC3T3-
E1 cells using Trizol reagent (Invitrogen, Carlsbad,
NM, USA) according to the manufacturer’s instruc-
tions. Total RNA (2 μg) was reverse-transcribed using
the RevertAid First-Stand Synthesis System kit for the
real-time polymerase chain reaction (Thermo Fisher
Scientific, Pittsburgh, PA, USA) according to the
manufacturer’s protocol. Real-time PCR was per-
formed on an ABI 7500 Fast Real-Time PCR System
(Applied Biosystems 7500 System Sequence Detection
System, software version 2.6.1) using SYBR Green
PCR Master Mix (Applied Biosystems, Foster City,
CA, USA). The running conditions were as follows:
The temperature profile of the reaction was 95 °C for
15 min, followed by 40 cycles of denaturation at 95 °C for
30 s, annealing at 58 °C for 30 s, and extension at
72 °C for 60 s. The primers used in this study are
shown in Table 1.
Statistical analysis
All the experiments were performed in triplicate, and
the results were expressed as the mean ± SD. Statistical
analyses were performed with the SPSS 13.0 statistical
software program (SPSS Inc., IL, USA). A one-way
ANOVA was used for multiple comparisons in the
statistical analysis.
Results
Kaempferol did not exert a cytotoxic effect below 50 μM
in the MC3T3-E1 cells
We first examined the cytotoxicity of kaempferol over a
wide concentration range using an MTT assay in the
MC3T3-E1 cells. The cells were treated with kaempferol
(0.1–1000 μM) and incubated for 24–72 h. At
0.1–50 μM, the kaempferol treatment had no cytotoxic
effect. However, over 50 μM, it potently reduced the via-
bility of the MC3T3-E1 cells in a dose-dependent man-
ner. Low concentrations of kaempferol (less than
50 μM) did not have a significant effect on the viability
or survival of the MC3T3-E1 cells (Fig. 2) or on the in-
duction of differentiation, mineralization, or autophagy
in later experiments. Thus, we used a concentration of
kaempferol below 50 μM in subsequent experiments.
Kaempferol induced the differentiation, mineralization of
osteoblasts and the markers gene expression of
osteoblasts in the MC3T3-E1 cells
To determine the concentration of kaempferol that
controlled the differentiation and mineralization of oste-
oblasts, we performed an ALP activity assay and alizarin
red staining. The ALP activity was used as an initial indi-
cator of osteoblast differentiation. ALP activity was
decreased at a concentration above 10 μM. To evaluate
the ALP activity, the cells were treated with various con-
centrations of kaempferol (1, 2.5, 5, 10, 50 and 100 μM)
and incubated for 3 to 7 days. As shown in Fig. 3a, ALP
activity increased significantly in accordance with the
increase in the concentration of kaempferol after 7 days.
The level of ALP activity of was particularly high at a
kaempferol concentration of 10 μM, but the effect de-
creased after 3 days of the treatment.
Osteoblasts give rise to bone formation through a process
of cell proliferation, differentiation and mineralization.
During mineralization, they produce extracellular calcium
deposits, which can be detected by alizarin red
Table 1 Primers used in this study






Fig. 2 Cytotoxic effect of kaempferol on the MC3T3-E1 cells. The
cytotoxicity of various concentrations of kaempferol to MC3T3-E1
cells exposed to the treatment for 24–72 h was determined with an
MTT assay. Concentrations of 0.1–10 μM had no obvious effect on
the cells. However, concentrations over 10 μM significantly reduced
the viability of the MC3T3-E1 cells compared with untreated controls.
The data are expressed as the mean ± SD (n=6). The statistical
significance of each group was analyzed by a one-way ANOVA and
Tukey’s HSD test (*p < 0.05, **p < 0.01, ***p < 0.001 at 24 h, #p < 0.05,
##p < 0.01, ###p < 0.001 at 48 h, and †p < 0.05, ††p < 0.01, †††p < 0.001
at 72 h for the difference between the treatment group (0.1–1000 μM)
compared to the non-treated group (0 μM))
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staining. The kaempferol-treated cells were incubated
for 7–14 days and then stained and quantified using
alizarin red and an ELISA reader. After 7 days,
kaempferol at a concentration of 10 μM induced cal-
cified nodules that stained a deep red color compared
to the control and other concentrations. The cells
were stained more deeply after 14 days of the kaemp-
ferol treatment than after 7 days, and the intensity of
the alizarin red was also greater (Fig. 3b). These re-
sults provide convincing evidence that kaempferol ef-
ficiently induces the differentiation and mineralization
of MC3T3-E1 cells at a concentration of 10 μM.
The effect of kaempferol on osteoblast differentiation
was further confirmed with Western blotting and real-
time PCR. After 24 h of the kaempferol treatment, the
total protein and RNA were isolated, and the expression
of the osteoblast differentiation makers, RUNX-2,
osterix, BMP-2 and collagen I, was analyzed. The protein
expression levels of all the genes increased in a dose-
dependent manner in response to the kaempferol treat-
ment. The mRNA levels showed dramatic results more
than Western blotting, especially, BMP-2 expression
level increases remarkably at 5–10 μM of kaempferol
(Fig. 4a, b). As kaempferol significantly increased ALP
activity, the intensity of alizarin red, and the mRNA
and/or protein levels of the osteogenic markers, we
elucidate that kaempferol induced osteoblastic differ-
entiation in the MC3T3-E1 cells and that it has
osteogenic potential.
Kaempferol induced autophagy
We next investigated whether autophagy occurred in
the kaempferol-treated MC3T3-E1 cells. We con-
firmed the formation of autophagic vacuoles in re-
sponse to kaempferol by staining with AO and MDC.
Autophagy is usually characterized by increased for-
mation of AVOs, which represent lysosomes and
autophagolysosomes. AVOs appear as red fluorescent
and punctate by AO and MDC. As shown in the
upper panel of Fig. 5a, red-colored autophagic vacu-
oles were observed following the treatment with
1–10 μM of kaempferol for 24 h. The formation of
MDC-labeled vacuoles was also observed in the
kaempferol-treated MC3T3-E1 cells but not in the
control cells (Fig. 5a, lower panel). EBSS was used as
a positive control of autophagy. The results of the
MDC and AO staining of autophagic vacuoles
indicated that the kaempferol treatment of the
MC3T3-E1 cells was sufficient to instigate an autoph-
agic response. To identify kaempferol-induced autoph-
agy in the MC3T3-E1 cells, we conducted a Western
blot assay to detect various autophagy markers, such as
beclin-1, SQSTM1/p62 and LC3. SQSTM1/p62 and
beclin-1, which are activated by autophagy, accumulated in
a dose-dependent manner in the kaempferol-treated
MC3T3-E1 cells. The conversion rates of LC3-I to LC3-II,
as well as the total levels of LC3 proteins, increased in the
kaempferol-treated MC3T3-E1 cells in a dose-dependent
manner. During autophagy, LC3-I was converted to LC3-II,
Fig. 3 Effect of kaempferol on osteoblast differentiation and mineralization. a The kaempferol treatment of the cultured MC3T3-E1 cells increased ALP
activity in a dose- (1–100 μM) and time-dependent (3 and 7 days) manner. The data are expressed as the mean ± SD (n=6). The statistical significance
of each group was analyzed by a one-way ANOVA and Tukey’s honestly significant difference (HSD) test (*p < 0.001, 0 μM [3 days], #p < 0.01, 0 μM
[7 days], and ##p < 0.001, 0 μM [7 days] for the difference between the control and treatment groups). b The addition of kaempferol (1–10 μM) in-
duced mineralization of the cultured osteoblasts. After 7 and 14 days of the kaempferol treatment, nodules were detected, and these increased in a
dose-dependent manner, as shown by alizarin red staining. The data are expressed as the mean ± SD (n=6). The statistical significance of each group
was analyzed by a one-way ANOVA and Tukey’s HSD test (*p < 0.001 at 7 days and ##p < 0.001 at 14 days for the difference between the control and
treatment groups)
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it is the most representative and important event in
the autophagic process. The kaempferol-induced con-
version of LC3-I to LC3-II demonstrates that this
treatment can induce autophagy, as shown in the pre-
vious experiments (Fig. 5b, c).
Kaempferol-induced autophagy was associated with the
differentiation of osteoblasts
Finally, we hypothesized that kaempferol-induced au-
tophagy was associated with osteoblast differentiation
and bone formation. To test this hypothesis, we used
Fig. 5 Induction of autophagy in the kaempferol-treated MC3T3-E1 cells. a The cells were grown on coverslips and treated with various concentrations
of kaempferol (1–10 μM) for 24 h. The formation of autophagosomes and autolysosomes was analyzed by fluorescence microscopy. The upper and
lower panels show images of AO and MDC staining, respectively, captured using a fluorescence microscope. Scale bar, 50 μm. b Western blotting used
antibodies specific for beclin-1, SQSTM1/p62, LC3 and β-actin. β-actin was used as an internal control. The results shown are representative of at least
three replicates. c After kaemferol treatment, the LC3-II to LC3-I ratio is increased in dose-dependently
Fig. 4 Effect of kaempferol on osteogenesis-associated factors. a The cells were treated with kaempferol (1–10 μM) for 24 h. Western blotting
showed that kaempferol activated the osteogenic proteins such as RUNX-2, osterix, BMP-2 and collagen I. β-actin was used as the internal control.
b The total RNA was extracted from the cultures to perform quantitative PCR. The mRNA expression of osteogenesis-associated genes, including
BMP-2, ALP and collagen I, increased in a dose-dependent manner. The data are expressed as the mean ± SD (n=6). The statistical significance of
each group was analyzed by a one-way ANOVA and Tukey’s HSD test (*p < 0.05 [BMP-2], **p < 0.001 [BMP2], #p < 0.001 [ALP], and †p < 0.001
[collagen I] for the difference between the treatment group compared to the control group)
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3‐MA, which prevents autophagy by blocking autop-
hagosome formation via the inhibition of the type III
phosphatidylinositol 3-kinase (PI-3K), to determine
whether kaempferol-induced autophagy played an im-
portant role in the differentiation of the MC3T3-E1
cells. We found that 3-MA blocked the kaempferol-
induced osteogenic differentiation and mineralization,
as confirmed by a reduction in ALP activity and ali-
zarin red staining (Fig. 6a, b). In addition, as shown
in Fig. 7a, b and c, kaempferol activated autophagy-
related factors, including SQSTM1/p62, beclin-1,
ATG5 and LC3, but their induction was inhibited by
3-MA. This result clearly confirms that kaempferol is
associated with autophagy. 3-MA also blocked the in-
duction of osteoblast differentiation markers, such as
collagen I, BMP-2 and osterix, in addition to the
expression of RUNX-2 and osterix mRNA levels in-
duced by the kaempferol treatment in the MC3T3-E1
cells (Fig. 7d). These results clearly support the hy-
pothesis that kaempferol induces autophagy and that
autophagy activates osteoblast differentiation.
Discussion
Flavonoids are naturally occurring compounds found in
food in the human diet [6]. They are also used in medicine
[6]. Flavonoids are known to be very effective in the pre-
vention of cancer and cardiovascular, neurodegenerative
[24] and metabolic bone diseases [25]. Numerous recent
studies reported that flavonoids controlled osteoblast and
osteoclast functions [13, 17]. They showed that kaemp-
ferol, in particular, exerted a potent inhibitory effect on
the bone resorbing activity of osteoclasts [15] and that it
promoted osteoblastic differentiation and mineralization
of an osteoblastic cell line [16]. Autophagy has well-
known physiological and pathological roles in many
organs [26, 27]. However, the physiological roles of au-
tophagy in bone homeostasis and metabolic bone disease
are largely unknown [28]. Also studies of kaempferol have
shown that it has anti-inflammatory [29], breast cancer
prevention [30] and neuroprotection properties [31].
MC3T3-E1 cells have been used to investigate the modu-
latory effects of various flavonoids on osteogenic charac-
teristics. These cells provide a useful model for studying
bone cell proliferation and differentiation and a renewable
culture system to determine the molecular mechanism of
osteoblast maturation and the formation of the bone-like
extracellular matrix [32]. Therefore, in the present study,
we used MC3T3-E1 osteoblastic cells to determine the
osteogenesis and autophagy potential of kaempferol.
We first determined the concentration of kaempferol
that promoted osteoblast function by assessing the
mineralization of MC3T3-E1 cells. Kaempferol showed
cytotoxicity at concentrations greater than 10 μM. Re-
cently, Podder et al. [33] reported that kaempferol at
Fig. 6 Effect of 3-MA on the differentiation and mineralization of osteoblasts by kaempferol. a The MC3T3-E1 cells were pretreated with an
autophagy inhibitor, 3-MA (1 mM), for 1 h and then treated with 10 μM of kaempferol. ALP activity showed that 3-MA blocked the differentiation
of the MC3T3-E1 cells induced by the kaempferol (10 μM) treatment. The data are expressed as the mean ± SD (n=6). The statistical significance
of each group was analyzed by a one-way ANOVA and Tukey’s HSD test (*p < 0.001 [3 days] and #p < 0.001 [7 days] for the difference between
the control compared to the treatment group). b 3-MA also inhibited osteoblast mineralization induced by the addition of kaempferol, as shown
by alizarin red staining. The data are expressed as the mean ± SD (n=6). The statistical significance of each group was analyzed by a one-way
ANOVA and Tukey’s HSD test (*p < 0.001 [7 days] and #p < 0.001 [14 days] for the difference between the control group compared to the
treatment groups)
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concentrations up to 5 μM had no cytotoxic effects but
that it suppressed the MUC5AC gene, resulting in a
chronic cough and excessive sputum production. They
also reported that the treatment had a cyto-protection
effect in bronchial epithelium BEAS-2B cells. Another
study found that kaempferol (10 μM) activated the tran-
scriptional activity and induction of osteoblast differenti-
ation biomarkers, including ALP, and that it promoted
the mineralization of rat osteoblasts [34]. Increasing dif-
ferentiation and mineralization of osteoblasts is the ul-
timate aim of all bone anabolic therapy [35]. The activity
of ALP is known to be increased in osteoblasts in the
early phase of differentiation. ALP is an essential indica-
tor of the mineralization capacity, and it is expressed by
all osteoblastic cells. ALP activity was also reported to
be a characteristic of osteogenic cells in culture and to
promote bone matrix mineralization [36]. We observed
that kaempferol stimulated ALP activity and the forma-
tion of mineralized nodules at a maximum concentra-
tion of 10 μM in the MC3T3-E1 cells, thereby
suggesting a bone anabolic action for kaempferol in
osteoblasts. The transcription of genes for several bone
differentiation markers (collagen I, RUNX-2, osterix and
BMP-2) was up-regulated in response to the kaempferol
treatment in cultured osteoblasts. In all cases, the tran-
scripts encoding these markers were significantly
induced (two to three-fold) by kaempferol at a concen-
tration of 10 μM. At this concentration, the level of
BMP-2 increased 25-fold.
During autophagy, cytoplasmic materials are enclosed
in a double‐membrane structure called an autophago-
some, which fuses with lysosomes to form autolyso-
somes, where degradation of the cytoplasmic materials
occurs [28]. In addition to the role of autophagy in adap-
tive responses to starvation, quality control of intracellu-
lar proteins and organelles, antiaging, suppression of
tumor formation, elimination of intracellular microbes,
and antigen presentation, there is increasing evidence
that it plays important roles in differentiation and devel-
opment [28]. The essential proteins of autophagy
involved in autophagosome formation, ATG5, beclin-1
and LC3, that lead to early lethality, prevent us from
studying the physiological role of autophagy in bone de-
velopment [37]. The results of the present study provide
clear evidence for a positive role of autophagy in bone
development and osteoblast differentiation. Although
ATG5 and SQSTM1/p62 have been shown to regulate
autophagic degradation [38], their importance in bone
Fig. 7 Effect of kaempferol on osteogenic factors associated with autophagy. The relationship between kaempferol-induced autophagy and
osteogenic differentiation was confirmed via 3-MA, Western blotting (a, b, c) and real-time PCR (d). 3-MA clearly inhibited both autophagy and
the osteogenic factors activated by kaempferol. The data are expressed as the mean ± SD (n=6). The statistical significance of each group was
analyzed by a one-way ANOVA and Tukey’s HSD test (*p < 0.01 [LC3-II], #p < 0.01 [SQSTM1/p62], †p < 0.01 [Runx2] and ‡p < 0.01 [Osterix] for the
difference between the control compared to the treatment groups)
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cell activity is not yet known [20]. Recently, Ha et al
demonstrated that bioactive silica-based nanoparticle
formulation stimulates osteoblast differentiation and
autophagy including the increase in LC3β-II and
SQSTM1/p62, but its interaction has yet to be demon-
strated [19]. The conversion of cytosolic LC3-I to
autophagic vesicle-associated phospholipid conjugate
from LC3-II has been widely used to monitor autophagy
flux [31]. The lipidated form of LC3 transformed from
LC3-I to LC3-II is considered to be an autophagosomal
marker due to its localization and aggregation on autop-
hagosomes [32, 33]. Our data clearly showed that
kaempferol activated autophagic-related genes, such as
ATG5, beclin-1, SQSTM1/p62 and LC3, and that it in-
duced autophagosome formation. These findings suggest
that kaempferol augments autophagy in osteoblasts.
Given that 3‐MA might have effects on lysosomes
that are independent of autophagy, we used an alter-
nate approach to block the formation of autophago-
somes (i.e., knocking down the expression of key
autophagy genes, using either ATG5 or beclin-1 spe-
cific small interfering RNA) [39]. While early autoph-
agy inhibitor 3-MA inhibited the conversion of LC3-I
to LC3-II, we found that 3-MA reduced both osteo-
blast differentiation and the expression of osteogenic
gene makers, indicating that kaempferol induced
autophagy and that autophagy promoted osteoblast
differentiation of the MC3T3-E1 cells.
The present study, for the first time, demonstrate the
role of kaempferol in osteoblast differentiation and au-
tophagy. Methodological innovations in molecular bio-
logical studies and new animal models will help to shed
light on this issue. The findings of the current study may
help to delineate the potential role of kaempferol in the
treatment of bone metabolism disorders.
Conclusion
The present study showed that kaempferol stimulated
the osteogenic differentiation of cultured osteoblasts by
inducing autophagy.
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